| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | -0.14 | 1e-05 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | -0.2 | 1e-05 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-05 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.22 | 4e-05 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.18 | 0.0002 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0003 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.18 | 0.0003 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0003 |